Catalog No.:AA00G9AH

830346-50-4 | 3-[(2R)-2-Amino-2-phenylethyl]-5-(2-fluoro-3-methoxyphenyl)-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-6-methyl-2,4(1H,3H)-pyrimidinedione

Name: Name:3-[(2R)-2-Amino-2-phenylethyl]-5-(2-fluoro-3-methoxyphenyl)-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-6-methyl-2,4(1H,3H)-pyrimidinedione
Brand: AABLOCKS
SKU: AA00G9AH
Availability: InStock
Rating: 90 (10 reviews)

Pack Size

Purity

Availability

Price(USD)

Quantity

97%

2 weeks

$850.00 $595.00

- +

Technical Information
Properties
Downstream Synthesis Route
Literature
Request for Quotation
Download SDS

Technical Information
Properties
Downstream Synthesis Route
Literature

Technical Information

Catalog Number:

AA00G9AH

Chemical Name:

3-[(2R)-2-Amino-2-phenylethyl]-5-(2-fluoro-3-methoxyphenyl)-1-[[2-fluoro-6-(trifluoromethyl)phenyl]methyl]-6-methyl-2,4(1H,3H)-pyrimidinedione

CAS Number:

830346-50-4

Molecular Formula:

C28H24F5N3O3

Molecular Weight:

545.5005

MDL Number:

MFCD31811619

SMILES:

CC1=C(C(=O)N(C(=O)N1CC2=C(C=CC=C2F)C(F)(F)F)CC(C3=CC=CC=C3)N)C4=C(C(=CC=C4)OC)F

Properties

Downstream Synthesis Route

N-{(R)-2-5-(2-fluoro-3-methoxy-phenyl)-4-methyl-2,6-dioxo-3,6-dihydro-2H-pyrimidin-1-yl-1-phenyl-ethyl}-2,2-dimethyl-propionamide

239087-08-2

830346-50-4

[1]Patent:WO2009/62087,2009,A1.Locationinpatent:Page/Pagecolumn15,16

1150560-59-0

102089-75-8

830346-50-4

[1]CurrentPatentAssignee:NEUROCRINEBIOSCIENCESINC-WO2009/62087,2009,A1Locationinpatent:Page/Pagecolumn8;11

[2]CurrentPatentAssignee:NEUROCRINEBIOSCIENCESINC-WO2009/62087,2009,A1Locationinpatent:Page/Pagecolumn8;12

[3]CurrentPatentAssignee:CHINANATIONALPHARMACEUTICALGROUPCORPORATION-CN110498771,2019,ALocationinpatent:Paragraph0149-0151

[4]CurrentPatentAssignee:CHINANATIONALPHARMACEUTICALGROUPCORPORATION-CN110498770,2019,ALocationinpatent:Paragraph0075;0107-0109

830346-50-4

834153-87-6

[1]CurrentPatentAssignee:ANDIKANGWUXIBIOLOGICALTECH-CN108129400,2018,A

[2]CurrentPatentAssignee:CHINANATIONALPHARMACEUTICALGROUPCORPORATION-CN110498771,2019,A

[3]CurrentPatentAssignee:CHINANATIONALPHARMACEUTICALGROUPCORPORATION-CN110498770,2019,A

[4]CurrentPatentAssignee:SHANGHAIMOAOHAOPHARMACEUTICALTECH-CN114835650,2022,A

1150560-59-0

110143-62-9

830346-50-4

[1]Patent:CN108129400,2018,A.Locationinpatent:Paragraph0037;0043;0044

1150560-54-5

830346-50-4

[1]CurrentPatentAssignee:ANDIKANGWUXIBIOLOGICALTECH-CN108129400,2018,A

[2]CurrentPatentAssignee:LIVZONPHARMACEUTICALGROUPINC.-CN110437159,2019,A

[3]CurrentPatentAssignee:LIVZONPHARMACEUTICALGROUPINC.-CN110437159,2019,A

[4]CurrentPatentAssignee:SCINOPHARMTAIWAN,LTD.-US2021/78956,2021,A1

[5]CurrentPatentAssignee:SCINOPHARMTAIWAN,LTD.-US2021/78956,2021,A1

[6]CurrentPatentAssignee:SCINOPHARMTAIWAN,LTD.-US2021/78956,2021,A1

Literature

Quotation Request

Company Name:

Contact Person:

Email:

Quantity Required:

Country:

Additional Info:

SDS